Labcorp Holdings ( ($LH) ) has issued an update. On December 30, 2025, Labcorp announced it would participate in a fireside chat at the 44th ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q3, starting ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

The Association of Medical Laboratory Scientists of Nigeria (AMLSN) has warned that the growing trend of pharmacies ...

Diagnostic chains are expanding laboratories, integrated centres and collection networks as demand grows for preventive, ...

Preeclampsia Diagnostics Market Forecast-2032, report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. According to ...

Fulgent Genetics has agreed to acquire select assets of Bako Diagnostics, an Alpharetta, Georgia-based pathology laboratory ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks Cofactor Genomics, a ...

Modern Diagnostic IPO is being offered at a price band of ₹85 to ₹90 per share, with a lot size of 1,600 shares ...

SIGNIFICANT progress has been made in TB diagnostics in the past decade as countries in the African region embrace new ...